国药现代：马来酸依那普利片通过仿制药一致性评价

Core Viewpoint - The company, China National Pharmaceutical Group Modern (国药现代), has received approval from the National Medical Products Administration for the supplementary application of Enalapril Maleate Tablets (5mg), which has passed the consistency evaluation of generic drug quality and efficacy [1] Group 1 - The approved drug, Enalapril Maleate Tablets, is an angiotensin-converting enzyme (ACE) inhibitor [1] - The primary indications for Enalapril Maleate Tablets include the treatment of essential hypertension, renovascular hypertension, and symptomatic heart failure [1]